Latest News & Updates

New Cervical Cancer Guidelines Released
March 26, 2024

Continue Reading »

Judge Grants Biden Administration Motion to Dismiss Legal Challenge from PhRMA
February 26, 2024

Continue Reading »

Session Midpoint Report: What Physicians Should Know
February 21, 2024

Continue Reading »

2024 MEDPARD Available Now!
February 21, 2024

Continue Reading »

FDA grants accelerated approval to tarlatamab-dlle for extensive stage small cell lung cancer
May 16, 2024

Continue Reading »

FDA grants accelerated approval to lisocabtagene maraleucel for follicular lymphoma
May 15, 2024

Continue Reading »

FDA approves tisotumab vedotin-tftv for recurrent or metastatic cervical cancer
April 29, 2024

Continue Reading »

FDA grants accelerated approval to tovorafenib for patients with relapsed or refractory BRAF-altered pediatric low-grade glioma
April 23, 2024

Continue Reading »

Get More from FLASCO With Your Partnership

The Corporate Partnership Program allows FLASCO to expand our offerings to our partneres. Every FLASCO meeting also provides the industry representative with opportunities to educate our partners. When you send representatives to a FLASCO meeting, you are allowing them to share their knowledge, as well as receive the same knowledge as our members by participating within the educational sessions. This helps ensure that the hematology and oncology community at large are learning, sharing best practices, and finding solutions to problems together.

Corporate Partners

Diamond Elite




Upcoming Events

Click to view full events calendar.

May 25, 2024 7:30 am
Veterans Living With Cancer
June 19, 2024
June 26, 2024

We're Here to Help Contact Us

Contact Us

Add your name, email & message below: